Histone Deacetylase Enzymes as Potential Drug Targets in Cancer and Parasitic Diseases

Journal of Biomedicine and Biotechnology
doi 10.1155/jbb/2006/13474
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

Nuclear Receptors: Emerging Drug Targets for Parasitic Diseases

Journal of Clinical Investigation
Medicine
2017English

NOX Enzymes as Drug Targets

Cellular and Molecular Life Sciences
Molecular NeuroscienceMolecular MedicineCell BiologyMolecular BiologyPharmacologyCellular
2012English

Histone Deacetylase Inhibitors as Cancer Therapeutics

Annals of Translational Medicine
Medicine
2016English

Histone Deacetylase Inhibitors as Therapeutic Agents for Cancer Therapy: Drug Metabolism and Pharmacokinetic Properties

2011English

Transporters as Drug Targets in Neurological Diseases

Clinical Pharmacology and Therapeutics
Pharmacology
2016English

Histone Deacetylases as Targets for Treatment of Multiple Diseases

Clinical Science
Medicine
2013English

Histone Deacetylase Inhibitors in Cancer Therapy

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2009English

Oxidized Phospholipids as Potential Novel Drug Targets

Biophysical Journal
Biophysics
2007English

Histone Deacetylase 6 (HDAC6); Histone Deacetylase 8 (HDAC8)

Science-Business eXchange
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy